RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $364,000 | -20.2% | 133,384 | -3.3% | 0.04% | -21.4% |
| Q1 2017 | $456,000 | +0.4% | 137,884 | -27.7% | 0.06% | -30.9% |
| Q4 2016 | $454,000 | -26.2% | 190,605 | +13.8% | 0.08% | -44.1% |
| Q3 2016 | $615,000 | +36.7% | 167,505 | -17.0% | 0.14% | +28.3% |
| Q2 2016 | $450,000 | -20.8% | 201,738 | -26.1% | 0.11% | -38.6% |
| Q1 2016 | $568,000 | +30.0% | 272,895 | +89.4% | 0.18% | -30.0% |
| Q4 2015 | $437,000 | – | 144,100 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |